98 related articles for article (PubMed ID: 15590188)
21. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Rosenfeld PJ; Heier JS; Hantsbarger G; Shams N
Ophthalmology; 2006 Apr; 113(4):623.e1. PubMed ID: 16581423
[TBL] [Abstract][Full Text] [Related]
22. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA
Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439
[TBL] [Abstract][Full Text] [Related]
23. Low power vs standard power transpupillary thermotherapy in patients with age-related macular degeneration and subfoveal choroidal neovascularization ineligible for photodynamic therapy.
Hogan AC; Kilmartin DJ
Eye (Lond); 2006 Jun; 20(6):649-54. PubMed ID: 16082398
[TBL] [Abstract][Full Text] [Related]
24. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Harder B
Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy for age-related macular degeneration: no more pilot studies please.
Goverdhan SV; Gibbs FA; Lotery AJ
Eye (Lond); 2005 Nov; 19(11):1137-41. PubMed ID: 15543181
[No Abstract] [Full Text] [Related]
26. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
27. [Results of limited macular translocation in subfoveal choroidal neovascularization in age-related macular degeneration].
Pawlak D; Glacet-Bernard A; Papp M; Coscas G; Soubrane G
J Fr Ophtalmol; 2004 Nov; 27(9 Pt 2):3S31-7. PubMed ID: 15602405
[TBL] [Abstract][Full Text] [Related]
28. A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration.
Nguyen QD; Shah SM; Hafiz G; Quinlan E; Sung J; Chu K; Cedarbaum JM; Campochiaro PA;
Ophthalmology; 2006 Sep; 113(9):1522.e1-1522.e14. PubMed ID: 16876249
[TBL] [Abstract][Full Text] [Related]
29. Complement Factor P in choroidal neovascular membranes of patients with age-related macular degeneration.
Wolf-Schnurrbusch UE; Stuck AK; Hess R; Wolf S; Enzmann V
Retina; 2009; 29(7):966-73. PubMed ID: 19584655
[TBL] [Abstract][Full Text] [Related]
30. Pegaptanib: new drug. In macular degeneration: too many risks for too little benefit.
Prescrire Int; 2006 Aug; 15(84):127-9. PubMed ID: 16989023
[TBL] [Abstract][Full Text] [Related]
31. [The results of randomized controlled trial of low-dose radiation for wet-type age-related macular degeneration on a 1 year term basis].
Nippon Ganka Gakkai Zasshi; 2003 Jun; 107(6):326-30. PubMed ID: 12854503
[TBL] [Abstract][Full Text] [Related]
32. Late effects of X irradiation on regulation of cerebral blood flow after whole-brain exposure in rats.
Keyeux A; Brucher JM; Ochrymowicz-Bemelmans D; Charlier AA
Radiat Res; 1997 May; 147(5):621-30. PubMed ID: 9146708
[TBL] [Abstract][Full Text] [Related]
33. It is not time to abandon radiotherapy for neovascular age-related macular degeneration.
Fine SL; Maguire MG
Arch Ophthalmol; 2001 Feb; 119(2):275-6. PubMed ID: 11176992
[No Abstract] [Full Text] [Related]
34. External beam radiation therapy for CNV.
Chakravarthy U; Hart P; Finger P
Ophthalmology; 1998 Oct; 105(10):1790-1; author reply 1791-2. PubMed ID: 9787339
[No Abstract] [Full Text] [Related]
35. [3 years experience with low dosage fractionated percutaneous teletherapy in subfoveal neovascularization. Clinical results].
Schittkowski M; Schneider H; Grüschow K; Ziegler PG; Guthoff R; Fietkau R
Strahlenther Onkol; 2001 Jul; 177(7):345-53. PubMed ID: 11505620
[TBL] [Abstract][Full Text] [Related]
36. Early effects of ionizing radiation on the microvascular networks in normal tissue.
Roth NM; Sontag MR; Kiani MF
Radiat Res; 1999 Mar; 151(3):270-7. PubMed ID: 10073664
[TBL] [Abstract][Full Text] [Related]
37. [Radiotherapy in age-related macular degeneration].
Jaakkola A; Immonen I
Duodecim; 1998; 114(3):275-8. PubMed ID: 10895502
[No Abstract] [Full Text] [Related]
38. [Low dosage, fractionated, percutaneous teletherapy of subfoveal choroid neovascularization].
Schittkowski MP; Schneider H; Ziegler PG; Vogel S; Guthoff R
Ophthalmologe; 1998 Jul; 95(7):466-72. PubMed ID: 9738375
[TBL] [Abstract][Full Text] [Related]
39. [Radiotherapy of exudative senile macular degeneration. A prospective controlled study].
Anders N; Stahl H; Dorn A; Walkow T; Hosten N; Wust P; Hartmann C; Wollensak J
Ophthalmologe; 1998 Nov; 95(11):760-4. PubMed ID: 9857636
[TBL] [Abstract][Full Text] [Related]
40. Sham radiation in clinical trials assessing radiotherapy for exudative age-related macular degeneration.
Marcus DM; Camp MW; Sheils WC; McIntosh SB; Leibach DB; Johnson MH; Samy CN
Retina; 1999; 19(6):525-30. PubMed ID: 10606453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
